Melanoma

Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894

PH-894 protection for chemical structure, genetic sequencing and broad application for proliferative and infectious diseases in U.S.King of Prussia, Pennsylvania--(Newsfile...

Medical Care Technologies Continues Rigorous Testing of MDCE Melanoma Scan While Evaluating Expansion Opportunities (OTC Pink:MDCE)

Company Maintains Active Development of Core AI Imaging Technology Alongside Diversified Revenue Platforms and Strategic Growth Considerations MESA, AZ /...

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

NANJING, China, Aug. 02, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code:...

Medical Care Technologies Demonstrates Broad Monetization Power Across AI Vision, Software Development and Digital Platforms (OTC Pink:MDCE)

From Mobile Apps and Enterprise Web Solutions to AI Authentication and Auction Software - MDCE Continues Building Revenue Streams While...

Award-Winning Author Euran Daniels to Deliver Opening Keynote at International Nevus Outreach Conference, Unveiling New $100,000 Global Initiative to Advance CMN Research and Awareness

ORLANDO, Fla., July 24, 2026 /PRNewswire/ -- Award-winning author, entrepreneur, and Congenital Melanocytic Nevus (CMN) advocate Euran S. Daniels will deliver the...

Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Live Presentation and Q&A: Tuesday, July 28, 2026 12 PM EDTKing of Prussia, Pennsylvania--(Newsfile Corp. - July 22, 2026) -...

Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC

SHANGHAI, July 21, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...

Medical Care Technologies (OTC PINK:MDCE) Showcases Diversified Strength and Positions AI Vision Platform for Multi-Billion Dollar Wound Care Market

Subsidiaries Infinite Auctions and Real Game Used Deliver Revenue Momentum While MDCE Advances Melanoma Scan Beta and Wound Monitoring Initiatives...

Medical Care Technologies, Inc. (OTC PINK:MDCE) Advances Melanoma Scan Beta Through Comprehensive AI Model Optimization Using Gold-Standard Datasets

Internal Testing Demonstrates Strong Technical Progress and Positions MDCE for Growth in AI-Powered Preventive Wellness MESA, AZ / ACCESS Newswire...

Medical Care Technologies Showcases Strength of Operating Subsidiaries with New Websites, Automated Systems, and Star-Powered Auction Momentum

Infinite Auctions and Real Game News Deliver Tangible Results and Non-Dilutive Funding for Core Technology Initiatives MESA, AZ / ACCESS...

Medical Care Technologies Subsidiary Infinite Auctions Surges Past $158,000 in High-Profile Memorabilia Auction with Explosive Viewer Engagement

Iconic LeBron, Kobe, and Iverson Game Worn Items Headline Event Generating Non-Dilutive Capital for Operations and Technology Development MESA, AZ...

Medical Care Technologies Inc. (OTC Pink:MDCE) Advances Beyond Original AI Vision Patent – Technology Has Evolved Faster Than Expected

Rapid Internal Innovation Renders U.S. Provisional Patent Application No. 63/854,935 Obsolete, Highlighting Exceptional Velocity in AI Development MESA, AZ /...

error: Content is protected !!